Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 3
Review
Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,190 | Dovepress* | 6,190+ | 1,901 | 8,091 | |
| Totals | 6,190 | 1,901 | 8,091 | ||
|
*Since 6 June 2008 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 1 | 0 | 0 | 0 | 3 |
View citations on Google Scholar